NEW YORK, Sept.

CHICAGO, July 22 /PRNewswire-FirstCall/ -- Ovarian malignancies are a leading cause of cancer death in women because they are usually detected in the late stages when the disease is incurable.

WASHINGTON, July 30 /PRNewswire-FirstCall/ -- The ability of blood tests to precisely measure very low doses of anti-rejection drugs in kidney transplant patients may make a significant difference in assuring long-term viability and survival, according to research presented today at the American Association for Clinical Chemistry (AACC) annual meeting.

RICHMOND, British Columbia, May 2, 2007 (PRIME NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) is pleased to provide an update of its activities to its shareholders. The Company has been working diligently and effectively in expanding its technology in the scientific and business arenas.